Draft Genome Sequence of a Metronidazole-Susceptible Atopobium vaginae Isolate

Genome Announcements
Jessica A SchuylerDavid W Hilbert

Abstract

We report the draft genome sequence of a vaginal isolate of Atopobium vaginae vaginae (strain 44061), an organism linked to bacterial vaginosis (BV), the most common gynecological infection in the United States. This species is often highly resistant to metronidazole, which is a front-line therapy for BV. Strain 44061 is a metronidazole-susceptible isolate (MIC, 16 µg/ml), and its genome sequence will be useful for comparative studies to elucidate the molecular basis of metronidazole resistance in this species.

References

Sep 28, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Emilia H KoumansUNKNOWN CDC BV Working Group
Mar 18, 2006·BMC Infectious Diseases·Ellen De BackerMario Vaneechoutte
Jan 14, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sonja LöfmarkCarl Erik Nord
Mar 11, 2010·AIDS Patient Care and STDs·Hamish MohammedPatricia Kissinger

❮ Previous
Next ❯

Citations

Jun 1, 2016·Frontiers in Microbiology·Boris ShaskolskiyDmitry Gryadunov

❮ Previous
Next ❯

Datasets Mentioned

BETA
LFWE00000000

Software Mentioned

GS Reference Mapper
GS De Novo Assembler

Related Concepts

Related Feeds

Bacterial Vaginosis

Bacterial vaginosis can increase the risk of sexually transmitted infections and in rare cases lead to pelvic inflammatory diseases. Discover the latest research on Bacterial Vaginosis here.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.